PPT-Future HCV Treatment Paradigms

Mark Sulkowski MD Professor of Medicine Medical Director Viral Hepatitis Center Divisions of Infectious Diseases and Gastroenterology Hepatology Johns Hopkins Medical Institutions Baltimore Maryland USA. Whist eery eo rt is made to ensure accuracy there may be phonetic or other errors depending on ineitabe a riations in recording 0uaity Pease do contact us to point out any errors 1hich 1e 1i endeaour to co rrect To reproduce any part o this transcri paradigms Paul Kiparsky Stanford University Paradigms that combine (one-word) and forms bution have large discussions of (McCloskey and Poser Andrews 1990). Such paradigms lexicalist words sentences o Results from SILEN-C1 in HCV genotype-1 treatment-naïve patients across different baseline factors. Disclosures. Introduction. SILEN-C1 trial. Virologic response. a. Methods. Baseline characteristics. HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Trial. Phase . 3. Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Treatment. Naïve and Treatment . Experienced. HIV Coinfection. Source: . Sulkowski. MS, et al. JAMA. 2014;312:353-61.. Highly-parallel Accelerators. Marc . S. Orr. PhD Defense, . December . 5. , . 2016. Advisor: David A. Wood. Committee. : Brad Beckmann, Mark Hill, Nam . Sung Kim,. Karu. . Sankaralingam. , and Mike Swift. . Case. 47-Year-Old . Man With Asymptomatic HIV Infection. Case (cont). Initial Clinical Presentation. Laboratory Results. HepaScore. ®. A Composite Biomarker Panel for Liver Fibrosis. Hepatic Steatosis in Patients With HIV/HCV Coinfection. Strategies To Identify and Advance PWID HCV Patient Care. Linkage to C Care Program. . Imtiaz Alam, M.D.. Medical Director, Austin Hepatitis Center. Medical Director, . HepCare. Specialty Pharmacy. IAPAC African Regional Capacity-Building Hub. Based in Johannesburg, South Africa. Mission: Strengthen clinician capacity to deliver HIV, HBV, and HCV treatment . Partners include:. . Supported through an educational grant from: . IAPAC African Regional Capacity-Building Hub. Based in Johannesburg, South Africa. Mission: Strengthen clinician capacity to deliver HIV, HBV, and HCV treatment . Partners include:. . Supported through an educational grant from: . HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community Dr John Lambert, Professor of Medicine and Consultant in Infectious Diseases, Mater Hospital and UCD Dublin Todd S. Wills, MD. Martha Friedrich, PhD. SPNS Hepatitis C Treatment Expansion Initiative. University of South Florida. The HIV/HCV Disease Burden. Hepatitis C. In U.S., 4 million HCV+ . →. 85% chronic . Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Yasuda,. 3. Chung-Feng Huang,. 4. Etsuko Iio,. 5. Charles Landis,. 6. Dae Won Jun,. 7. Masaru Enomoto,. 8. Eiichi Ogawa,. 9. Pei-. Chien. Tsai,. & . Update on HCV . blood bank protocol. . Overview - . diagnostic tests. Serologic . assays: . specific antibody to hepatitis C virus (anti-HCV). Molecular . assays: HCV nucleic acid . (. nucleic. Dr. Sonalika’s Eye Clinic provide the best Paediatric ophthalmology treatment, Paediatric eye checkup treatment in Pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri